Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
[No title available]

Access microbiology

Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R.
PMID: 35024552
Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021.

CASE PRESENTATION: To the best of our knowledge, here we present the first case of CONCLUSION: Despite its pathogenicity,

Cite
Gruwier L, Sprenkels A, Hulsbosch S, et al. . Access Microbiol. 2021;3(12):000290doi: 10.1099/acmi.0.000290.
Gruwier, L., Sprenkels, A., Hulsbosch, S., Vankeerberghen, A., & Cartuyvels, R. (2021). . Access microbiology, 3(12), 000290. https://doi.org/10.1099/acmi.0.000290
Gruwier, Lien, et al. "." Access microbiology vol. 3,12 (2021): 000290. doi: https://doi.org/10.1099/acmi.0.000290
Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R. . Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021. PMID: 35024552; PMCID: PMC8749150.
Copy Download .nbib Format: NLM
The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review.

Open forum infectious diseases

D'Onofrio V, Salimans L, Bedenić B, Cartuyvels R, Barišić I, Gyssens IC.
PMID: 33033730
Open Forum Infect Dis. 2020 Aug 13;7(10):ofaa352. doi: 10.1093/ofid/ofaa352. eCollection 2020 Oct.

Fast microbiological diagnostics (MDx) are needed to ensure early targeted antimicrobial treatment in sepsis. This systematic review focuses on the impact on antimicrobial management and patient outcomes of MDx for pathogen and resistance gene identification compared with blood cultures....

Cite
D'Onofrio V, Salimans L, Bedenić B, et al. The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review. Open Forum Infect Dis. 2020;7(10):ofaa352doi: 10.1093/ofid/ofaa352.
D'Onofrio, V., Salimans, L., Bedenić, B., Cartuyvels, R., Barišić, I., & Gyssens, I. C. (2020). The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review. Open forum infectious diseases, 7(10), ofaa352. https://doi.org/10.1093/ofid/ofaa352
D'Onofrio, Valentino, et al. "The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review." Open forum infectious diseases vol. 7,10 (2020): ofaa352. doi: https://doi.org/10.1093/ofid/ofaa352
D'Onofrio V, Salimans L, Bedenić B, Cartuyvels R, Barišić I, Gyssens IC. The Clinical Impact of Rapid Molecular Microbiological Diagnostics for Pathogen and Resistance Gene Identification in Patients With Sepsis: A Systematic Review. Open Forum Infect Dis. 2020 Aug 13;7(10):ofaa352. doi: 10.1093/ofid/ofaa352. eCollection 2020 Oct. PMID: 33033730; PMCID: PMC7528559.
Copy Download .nbib Format: NLM
[No title available]

Access microbiology

Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R.
PMID: 35024552
Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021.

CASE PRESENTATION: To the best of our knowledge, here we present the first case of CONCLUSION: Despite its pathogenicity,

Cite
Gruwier L, Sprenkels A, Hulsbosch S, et al. . Access Microbiol. 2021;3(12):000290doi: 10.1099/acmi.0.000290.
Gruwier, L., Sprenkels, A., Hulsbosch, S., Vankeerberghen, A., & Cartuyvels, R. (2021). . Access microbiology, 3(12), 000290. https://doi.org/10.1099/acmi.0.000290
Gruwier, Lien, et al. "." Access microbiology vol. 3,12 (2021): 000290. doi: https://doi.org/10.1099/acmi.0.000290
Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R. . Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021. PMID: 35024552; PMCID: PMC8749150.
Copy Download .nbib Format: NLM
[No title available]

Access microbiology

Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R.
PMID: 35024552
Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021.

CASE PRESENTATION: To the best of our knowledge, here we present the first case of CONCLUSION: Despite its pathogenicity,

Cite
Gruwier L, Sprenkels A, Hulsbosch S, et al. . Access Microbiol. 2021;3(12):000290doi: 10.1099/acmi.0.000290.
Gruwier, L., Sprenkels, A., Hulsbosch, S., Vankeerberghen, A., & Cartuyvels, R. (2021). . Access microbiology, 3(12), 000290. https://doi.org/10.1099/acmi.0.000290
Gruwier, Lien, et al. "." Access microbiology vol. 3,12 (2021): 000290. doi: https://doi.org/10.1099/acmi.0.000290
Gruwier L, Sprenkels A, Hulsbosch S, Vankeerberghen A, Cartuyvels R. . Access Microbiol. 2021 Dec 09;3(12):000290. doi: 10.1099/acmi.0.000290. eCollection 2021. PMID: 35024552; PMCID: PMC8749150.
Copy Download .nbib Format: NLM
Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study.

Open forum infectious diseases

D'Onofrio V, Meersman A, Vijgen S, Cartuyvels R, Messiaen P, Gyssens IC.
PMID: 33511231
Open Forum Infect Dis. 2020 Dec 28;8(1):ofaa594. doi: 10.1093/ofid/ofaa594. eCollection 2021 Jan.

BACKGROUND: There is a clear need for a better assessment of independent risk factors for in-hospital mortality, intensive care unit admission, and bacteremia in patients presenting with suspected sepsis at the emergency department.METHODS: A prospective observational cohort study including...

Cite
D'Onofrio V, Meersman A, Vijgen S, et al. Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study. Open Forum Infect Dis. 2020;8(1):ofaa594doi: 10.1093/ofid/ofaa594.
D'Onofrio, V., Meersman, A., Vijgen, S., Cartuyvels, R., Messiaen, P., & Gyssens, I. C. (2021). Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study. Open forum infectious diseases, 8(1), ofaa594. https://doi.org/10.1093/ofid/ofaa594
D'Onofrio, Valentino, et al. "Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study." Open forum infectious diseases vol. 8,1 (2021): ofaa594. doi: https://doi.org/10.1093/ofid/ofaa594
D'Onofrio V, Meersman A, Vijgen S, Cartuyvels R, Messiaen P, Gyssens IC. Risk Factors for Mortality, Intensive Care Unit Admission, and Bacteremia in Patients Suspected of Sepsis at the Emergency Department: A Prospective Cohort Study. Open Forum Infect Dis. 2020 Dec 28;8(1):ofaa594. doi: 10.1093/ofid/ofaa594. eCollection 2021 Jan. PMID: 33511231; PMCID: PMC7813192.
Copy Download .nbib Format: NLM
Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes.

International journal of antimicrobial agents

D'Onofrio V, Meersman A, Magerman K, Waumans L, van Halem K, Cox JA, van der Hilst JC, Cartuyvels R, Messiaen P, Gyssens IC.
PMID: 34161787
Int J Antimicrob Agents. 2021 Sep;58(3):106379. doi: 10.1016/j.ijantimicag.2021.106379. Epub 2021 Jun 20.

OBJECTIVES: To perform an audit of empirical antibiotic therapy (EAT) of sepsis at the emergency department and to analyse the impact of an antimicrobial stewardship (AMS) programme on process and patient outcomes.PATIENTS AND METHODS: A prospective, single-centre cohort study...

Cite
D'Onofrio V, Meersman A, Magerman K, et al. Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes. Int J Antimicrob Agents. 2021;58(3):106379doi: 10.1016/j.ijantimicag.2021.106379.
D'Onofrio, V., Meersman, A., Magerman, K., Waumans, L., van Halem, K., Cox, J. A., van der Hilst, J. C., Cartuyvels, R., Messiaen, P., & Gyssens, I. C. (2021). Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes. International journal of antimicrobial agents, 58(3), 106379. https://doi.org/10.1016/j.ijantimicag.2021.106379
D'Onofrio, Valentino, et al. "Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes." International journal of antimicrobial agents vol. 58,3 (2021): 106379. doi: https://doi.org/10.1016/j.ijantimicag.2021.106379
D'Onofrio V, Meersman A, Magerman K, Waumans L, van Halem K, Cox JA, van der Hilst JC, Cartuyvels R, Messiaen P, Gyssens IC. Audit of empirical antibiotic therapy for sepsis and the impact of early multidisciplinary consultation on patient outcomes. Int J Antimicrob Agents. 2021 Sep;58(3):106379. doi: 10.1016/j.ijantimicag.2021.106379. Epub 2021 Jun 20. PMID: 34161787.
Copy Download .nbib Format: NLM
Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19.

Diagnostic microbiology and infectious disease

Boeckmans J, Cartuyvels R, Hilkens P, Bruckers L, Magerman K, Waumans L, Raymaekers M.
PMID: 33689985
Diagn Microbiol Infect Dis. 2021 Jun;100(2):115350. doi: 10.1016/j.diagmicrobio.2021.115350. Epub 2021 Feb 18.

Detection of SARS-CoV-2 RNA in nasopharyngeal samples using the real-time reverse transcription polymerase chain reaction (rRT-PCR) is the gold standard for diagnosing COVID-19. Determination of SARS-CoV-2 RNA by rRT-PCR sometimes results in an inconclusive test result due to a...

Cite
Boeckmans J, Cartuyvels R, Hilkens P, et al. Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19. Diagn Microbiol Infect Dis. 2021;100(2):115350doi: 10.1016/j.diagmicrobio.2021.115350.
Boeckmans, J., Cartuyvels, R., Hilkens, P., Bruckers, L., Magerman, K., Waumans, L., & Raymaekers, M. (2021). Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19. Diagnostic microbiology and infectious disease, 100(2), 115350. https://doi.org/10.1016/j.diagmicrobio.2021.115350
Boeckmans, Joost, et al. "Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19." Diagnostic microbiology and infectious disease vol. 100,2 (2021): 115350. doi: https://doi.org/10.1016/j.diagmicrobio.2021.115350
Boeckmans J, Cartuyvels R, Hilkens P, Bruckers L, Magerman K, Waumans L, Raymaekers M. Follow-up testing of borderline SARS-CoV-2 patients by rRT-PCR allows early diagnosis of COVID-19. Diagn Microbiol Infect Dis. 2021 Jun;100(2):115350. doi: 10.1016/j.diagmicrobio.2021.115350. Epub 2021 Feb 18. PMID: 33689985; PMCID: PMC7891066.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries